Patients with nonmetastatic prostate cancer treated according to NCCN Guidelines are more likely to die of other natural ...

Men with non-metastatic forms are likely to live 'for many years' after diagnosis when active surveillance and other NCCN ...

Real-world data suggest that Erleada may offer an advantage over other treatment options for patients with metastatic ...

Prostate cancer focal therapies include cryotherapy, irreversible electroporation ablation (IRE), & high-intensity focused ultrasound (HIFU).

Journal of the National Comprehensive Cancer Network finds that for people diagnosed with nonmetastatic low-risk prostate ...

A Florida man kept a promise to his father by completing a cross-country cycling race as his dad simultaneously underwent ...

The addition of metformin “was generally well tolerated but did not result in the targeted benefit of a 20% reduction in risk of death in an unselected population,” the researchers wrote.

The purpose of these estimates is to inform state and local cancer care organizations and providers, patient support programs ...

A new study by University of Michigan Rogel Cancer Center researchers identifies a cellular signature that explains why about ...

Prostate cancer is a stealthy disease with no attention-grabbing symptoms at first. It’s also a private and sensitive topic that men don’t want to discuss. But for men age 40 and older, it’s a good ...

A breakthrough in prostate cancer treatment is now available in Cincinnati, and it changed one patient's life faster than he ...

PEOPLE and Verywell Health joined forces to share facts about prostate cancer, plus unique perspectives from men with the ...